Updated results from a phase I/II study of mobocertinib (TAK788) in NSCLC with EGFR exon 20 insertions (exon20ins) Meeting Abstract

Industry Collaboration

cited authors

  • Riely, G. J.; Neal, J. W.; Camidge, D. R.; Spira, A.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A.; Patel, J.; Gadgeel, S.; Bazhenova, L.; Zhu, V. W.; West, H.; Mekhail, T.; Gentzler, R.; Nguyen, D.; Bunn, V.; Jin, S.; Feng, Z.; Janne, P. A.

authors

Publication Date

  • September 1, 2020

webpage

published in

category

start page

  • S815

end page

  • S816

volume

  • 31